ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand.
ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand.
复制标题
ELISA用于富含细胞色素c的人血清含有富含浅亮氨酸的α-2-糖蛋白-1作为捕获的配体。
DOI:
10.1016/j.jim.2008.03.004
复制
发表时间:
2008-07-20
影响因子:
2.2
通讯作者:
Jemmerson R
中科院分区:
文献类型:
--
作者:
Weivoda S;Andersen JD;Skogen A;Schlievert PM;Fontana D;Schacker T;Tuite P;Dubinsky JM;Jemmerson R
Leucine-rich alpha-2-glycoprotein-1 (LRG) is a serum glycoprotein of unknown function that has shown promise based on qualitative assessments as a biomarker for certain diseases including microbial infections and cancer. However, the lack of a quantitative assay for LRG has limited its application. Here an indirect enzyme-linked immunosorbent assay (ELISA) for quantifying LRG in human serum is described in which cytochrome c is employed as the capturing ligand and a monoclonal antibody specific for LRG is used to detect the captured glycoprotein. Application of this assay in quantifying LRG in various patients' sera is demonstrated. The concentration of LRG in sera of control subjects as determined by this assay is approximately 50 μg/ml. Consistent with expectations from published reports, LRG was found to be significantly elevated in the sera of some patients with a bacterial infection (toxic shock syndrome, TSS). LRG was only slightly elevated in patients infected with the human immunodeficiency virus as compared to uninfected control subjects, while normal levels of LRG were observed in patients with non-infectious diseases (inflammatory arthritis and neurological disorders, primarily Parkinson's disease). Although LRG and C-reactive protein (CRP) are both produced by the liver and are classified as acute-phase proteins, there was no significant correlation between the levels of LRG and CRP in the sera of the patients. Thus, LRG and CRP measurements are non-redundant and indicate different physiological contexts. The ELISA described in this report should be useful to further assess serum LRG as a biomarker for clinical diagnostics.
登录
查看更多内容
DOI:
10.1515/bchm2.1977.358.1.639
发表时间:
1977-01-01
影响因子:
--
作者:
HAUPT, H;BAUDNER, S
通讯作者:
BAUDNER, S
影响因子:
2.9
作者:
Bini, L;Magi, B;Pallini, V
通讯作者:
Pallini, V
影响因子:
7.2
作者:
Cummings, Chad;Walder, Jennifer;Jemmerson, Ronald
通讯作者:
Jemmerson, Ronald
DOI:
10.1016/j.jchromb.2007.01.029
发表时间:
2007-06-01
期刊:
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
影响因子:
--
作者:
Kakisaka T;Kondo T;Okano T;Fujii K;Honda K;Endo M;Tsuchida A;Aoki T;Itoi T;Moriyasu F;Yamada T;Kato H;Nishimura T;Todo S;Hirohashi S
通讯作者:
Hirohashi S
DOI:
10.1073/pnas.84.24.9180
发表时间:
1987-12-01
影响因子:
11.1
作者:
JEMMERSON, R
通讯作者:
JEMMERSON, R